Aussie University Produces Research Batch Of H1N1 Flu Vaccine
This article was originally published in PharmAsia News
An Australian university has produced the nation's first batch of H1N1 flu vaccine, but its 1,000 doses are available only for research purposes. The University of Queensland in Brisbane produced a liter of vaccine using a new technology that relies on the cells of insects instead of eggs. The school collaborated with U.S.-based Protein Sciences to produce the vaccine. (Click here for more
You may also be interested in...
Flagship Pioneering raised $1.1bn to fund life science companies emerging from Flagship Labs. ARCH, another frequent start-up co-founder, raised two funds totaling $1.46bn to back early-stage biotech.
LifeSignals plans to soon launch a biosensor patch to consumers to help them monitor for potential symptoms of COVID-19.
FDA and FTC's latest warning letters include the first firm marketing CBD products linked with bogus COVID-19 claims. Latest warnings also mark the first the agencies submitted based completely or nearly entirely on regulatory violations found in businesses social media postings.